Assembly Biosciences Inc. (ASMB) Live Share Price, Invest From India

Assembly Biosciences Inc. Stock Performance

as on June 27, 2026 at 2:16 pm IST

Day's Low
Day's High
$24.26
Day's Price Range
$26.88
$26.74
9.27%
Downside
0.52%
Upside
52 Week's Low
52 Week's High
$16.81
52-Week Price Range
$39.71
$26.74
37.15%
Downside
48.49%
Upside

Assembly Biosciences Inc. share price movements today

Previous Close: $24.26
Open: $24.29
Volume: 398.7K
Day's Low - High: $24.26 - $26.88
52 Week Low - High: $16.81 - $39.71

Assembly Biosciences Inc. Historical Returns

1 Month Return: -15.62 %
3 Month Return: -15.97 %
1 Year Return: + 42.04 %
3 Year Return: + 87.19 %
5 Year Return: -50.69 %

Assembly Biosciences Inc. Stock Fundamentals & Key Indicators

Check Assembly Biosciences Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$500.4M

EPS (TTM)

0.14

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

315.62

Industry PE ratio

-3.506255707762557

PEG Ratio

EBITDA

-13.4M

Revenue (TTM)

71.1M

Profit Margin

-8.98%

Return On Equity TTM

-5.66%

Assembly Biosciences Inc. Stock Valuation

Track how Assembly Biosciences Inc. P/E has moved over time to understand its valuation trends.

Assembly Biosciences Inc. in the last 5 years

Overview
Trends

Lowest (-43.52x)

December 31, 2025

Industry (-3.51x)

June 26, 2026

Today (315.63x)

June 26, 2026

Highest (-2.07x)

September 30, 2024

LowHigh

Today’s Price to Earnings Ratio: 315.63x

Assembly Biosciences Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Assembly Biosciences Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Assembly Biosciences Inc.	BUY	$500.4M	-50.69%	315.62	-8.98%	NA
Alnylam Pharmaceuticals Inc.	BUY	$39.3B	67.15%	74.07	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$120.6B	147.08%	28.17	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$65.4B	12.64%	15.22	29.65%	0.58%

Stock Returns calculator for Assembly Biosciences Inc. Stock including INR - Dollar returns

The Assembly Biosciences Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Assembly Biosciences Inc. investment value today

Current value as on today

₹1,72,389

Returns

₹72,389

(+72.39%)

Returns from Assembly Biosciences Inc. Stock

₹56,557 (+56.56%)

Dollar Impact

₹15,831 (+15.83%)

Analyst Recommendation on Assembly Biosciences Inc. Stock

Based on 8 analysts

BUY

75.00%

Buy

25.00%

Hold

0.00%

Sell

Based on 8 analysts, 75% of analysts recommend a 'BUY' rating for Assembly Biosciences Inc.. Average target price of $50

Assembly Biosciences Inc. Share Price Target

Get share price movements and forecasts by analysts on Assembly Biosciences Inc..

What analysts predicted

46.52%UPSIDE

Target Price

$50

Current Price

$26.74

Analyzed by

8 Analysts

Target

$50.00

Assembly Biosciences Inc. target price $50, a slight upside of 46.52% compared to current price of $26.74. According to 8 analysts rating.

Indian Investors' Interest in Assembly Biosciences Inc. Stock

Search interest for Assembly Biosciences Inc. Stock has increased by 9% in the last 30 days, reflecting an upward trend in search activity.

Time period: May 29, 2026 to June 28, 2026

Change:9% versus previous 30 day period

Assembly Biosciences Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Total Revenue	7	5	8	6	7	9	9	10	42	8
Gross Profit	7	5	8	-6	-6	-5	-6	10	42	8
Operating Income	-12	-10	-12	-10	-11	-9	-11	-10	19	-11
EBITDA	-10	-9	-10	-9	-10	-8	-10	-9	22	-9
Interest Expense	-	-	-	-	-	-	-	-	-	-
Depreciation	0	0	0	0	0	0	0	0	0	0
Income Before Tax	-10	-9	-10	-9	-10	-8	-10	-9	22	-9
Income Tax Expense	0	0	0	-	0	-	-	-	-	-
Net Income	-10	-9	-11	-9	-10	-8	-10	-9	22	-9
Net Profit Margin	-153.04%	-156.91%	-130.69%	-140.44%	-140.48%	-93.62%	-105.94%	-85.23%	52.01%	-110.54%

Assembly Biosciences Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	-	9	14	15	79	6	-	7	28	72
Gross Profit	0	-35	-57	15	-22	6	0	-41	-27	72
Operating Income	-45	-52	-92	-102	-64	-132	-94	-64	-45	-12
EBITDA	-44	-52	-92	-102	-58	-90	-93	-60	-39	-5
Interest Expense	-	-	-	4	2	82	0	-	-	-
Depreciation	-	0	0	0	0	0	0	0	0	0
Income Before Tax	-44	-51	-89	-98	-62	-132	-93	-61	-39	-6
Income Tax Expense	0	-9	1	0	-2	-2	-1	0	0	-
Net Income	-44	-42	-90	-97	-62	-129	-92	-61	-40	-6
Net Profit Margin	0.00%	-474.66%	-613.02%	-611.63%	-78.57%	-2076.35%	0.00%	-854.78%	-140.87%	-8.47%

Assembly Biosciences Inc. Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026
Net Income	-9	-11	-9	-10	-8	-10	-9	22	-9
Operating Cash Flow	-18	-17	-15	0	-23	-16	-15	14	-22
Investing Cash Flow	17	5	24	-6	6	16	-158	21	-5
Financing Cash Flow	-	12	-	16	1	0	171	0	0
Change in Cash	-1	0	9	9	-14	0	-1	35	-27

Assembly Biosciences Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-42	-90	-97	-62	-129	-93	-61	-40	-6
Operating Cash Flow	1	-64	-84	-62	-93	-84	22	-51	-41
Investing Cash Flow	-15	-135	-50	68	26	90	-69	40	-113
Financing Cash Flow	67	159	139	7	53	0	13	29	174
Change in Cash	53	-40	5	12	-13	6	-32	18	20

Global Institutional Holdings in Assembly Biosciences Inc.

Funds	Holdings
Paradigm Biocapital Advisors LP	3.36%
Tower Research Capital LLC	0%
Citadel Advisors Llc	0.23%
Parkman Healthcare Partners LLC	2.08%
HighVista Strategies LLC	0.47%

See all

Insights on Assembly Biosciences Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 7 days, ASMB stock has moved up by 9.4%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, ASMB has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, ASMB has outperformed top 5 stocks with highest market-cap in its industry

About Assembly Biosciences Inc.

Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases worldwide. Its pipeline includes long-acting helicase-primase inhibitors candidates, including ABI-5366 and ABI-1179, which are in Phase 1 clinical studies for recurrent genital herpes; and ABI-6250, an orally bioavailable hepatitis delta virus entry inhibitor that is in Phase 1a clinical study for the treatment of chronic hepatitis delta virus (HDV) infection. The company also develops ABI-4334, an orally bioavailable next generation capsid assembly modulator that is in Phase 1b study clinical trial for the treatment of chronic hepatitis B virus (HBV) infection; and ABI-7272, an oral broad-spectrum NNPI for the treatment of transplant-associated herpesviruses. It has an option, license, and collaboration agreement with Gilead Sciences, Inc. for the research and development of virology therapies. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.

Organisation	Assembly Biosciences Inc.
Headquarters	Two Tower Place, South San Francisco, CA, United States, 94080
Industry	Biotechnology
CEO	Mr. Jason A. Okazaki J.D.
E-voting on shares	Click here to vote

Key Management of Assembly Biosciences Inc.

Name	Title
Dr. William E. Delaney IV, Ph.D.	Chief Scientific Officer
Ms. Jeanette M. Bjorkquist	Principal Financial Officer, Executive Director of Accounting & Treasury
Ms. Jennifer A. Troia MHROD, SHRM-SCP, SPHR	Chief Human Resources Officer
Dr. Nicole S. White Ph.D.	Chief Manufacturing Officer
Ms. Katie Kitrinos	Senior VP of Preclinical Research & Development
Mr. Jason A. Okazaki J.D.	CEO, President & Director
Dr. Anuj Gaggar M.D., Ph.D.	Chief Medical Officer
Mr. Shannon Ryan	Senior Vice President of Investor Relations, Corporate Affairs & Alliance Management
Mr. Thomas E. Rollins	Executive Officer
Amy Figueroa C.F.A.	Investor Relations Consultant

FAQs

What is Assembly Biosciences Inc. share price today?

Assembly Biosciences Inc. share price today is $26.74 as on June 27, 2026 at 8:46 am IST at the close of the market. Assembly Biosciences Inc. share today touched a day high of $26.88 and a low of $24.26.

What is the 52 week high and 52 week low for Assembly Biosciences Inc. share?

Assembly Biosciences Inc. share touched a 52 week high of $39.71 on November 20, 2025 and a 52 week low of $16.81 on June 26, 2025. Assembly Biosciences Inc. stock price today i.e. June 27, 2026 at 8:46 am IST is closed at $26.74,which is 32.65% down from its 52 week high and 59.12% up from its 52 week low.

What is Assembly Biosciences Inc.'s market capitalisation today?

Assembly Biosciences Inc. market capitalisation is $0.00T as on June 27, 2026 at 8:46 am IST.

How to invest in Assembly Biosciences Inc. Stock (ASMB) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Assembly Biosciences Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Assembly Biosciences Inc. Shares that will get you 0.0561 shares as per Assembly Biosciences Inc. share price of $26.74 per share as on June 27, 2026 at 8:46 am IST.

What is the minimum amount required to buy Assembly Biosciences Inc. Stock (ASMB) from India?

Indian investors can start investing in Assembly Biosciences Inc. (ASMB) shares with as little as ₹94.3 or $1 (as of June 28, 2026 at 1:39 am IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.00 in Assembly Biosciences Inc. stock (as per the Rupee-Dollar exchange rate as on June 28, 2026 at 1:39 am IST). Based on Assembly Biosciences Inc. share’s latest price of $26.74 as on June 27, 2026 at 8:46 am IST, you will get 0.3740 shares of Assembly Biosciences Inc.. Learn more about fractional shares .

What are the returns that Assembly Biosciences Inc. has given to Indian investors in the last 5 years?

Assembly Biosciences Inc. stock has given -50.69% share price returns and 27.55% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?